Alkem Laboratories Limited (ALKEM.NS)

4,923.60 -50.00 (-1.01%) At close: 03:29PM IST

Alkem Laboratories Limited

Devashish Building
Alkem House Senapati Bapat Road Lower Parel (West)
Mumbai 400013
India
91 22 3982 9999
https://www.alkemlabs.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Basudeo Narian Singh	Executive Chairman	192.5M	N/A	1941
Mr. Sarvesh Singh	VP of Sales & Marketing and Executive Director	43.3M	N/A	1981
Mr. Sandeep Derjit Singh	MD & Executive Director	82.7M	N/A	1982
Mr. Mritunjay Kumar Singh	Executive Director	95.9M	N/A	1963
Mr. Srinivas Singh	Executive Director	98.91M	N/A	1989
Ms. Madhurima Singh	Executive Director	94.9M	N/A	1966
Dr. Vikas Gupta	Chief Executive Officer	N/A	N/A	N/A
Mr. Nitin Agrawal	Chief Financial Officer	N/A	N/A	N/A
Mr. Satish Kumar Singh	Head of Operations	N/A	N/A	1960
Ms. Purvi Shah	Head of Investor Relations	N/A	N/A	N/A

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.

Description

Alkem Laboratories Limited, a pharmaceutical company, engages in the development, manufacture, and sale of pharmaceutical and nutraceutical products in India and internationally. The company offers branded generics, generic drugs, active pharmaceutical ingredients, and biosimilars, and nutraceuticals in acute and chronic therapeutic areas comprising anti-infective, dermatology, cardiac, respiratory, gastro-intestinal, central nervous system, urology, and gynaecology, as well as vitamins, minerals, and nutrients; and pain analgesic, anti-diabetic, and neurology products. Alkem Laboratories Limited was incorporated in 1973 and is headquartered in Mumbai, India.

Corporate Governance

Alkem Laboratories Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.